PhD Admission: Doctoral Research Opportunities At The University of Basel, Switzerland

Doctoral Research Opportunities in NeuroImmunology at the University of Basel, Switzerland.

PhD Admission

PhD Admission: Doctoral Research Opportunities in NeuroImmunology at the University of Basel, Switzerland. The Clinical Neuroimmunology Laboratory, led by Professor Tobias Derfuss in the Department of Biomedicine, is preparing to offer two PhD positions. The first position is expected to be available in early Summer 2024, with a second position opening towards the end of 2024 or the beginning of 2025. The lab's research focuses on unraveling the causes and pathomechanisms of autoimmune diseases affecting the nervous system, with a particular emphasis on multiple sclerosis and myasthenia gravis.

The Department of Biomedicine is a joint effort between the University of Basel and the University Hospitals Basel. It unites basic and clinical scientists to advance our understanding of health and disease and tofuture develop pioneering therapies benefiting the lives of patients in areas of unmet need. With more than 70 research groups and 900 employees, the Department of Biomedicine is the largest department at the University. We are located in the heart of Basel at 6 different locations. Be part of our future!

The Clinical Neuroimmunology Laboratory in the Department of Biomedicine, headed by Professor Tobias Derfuss, is planning to open a PhD position in early Summer of 2024 and a second position at the end of 2024 or early 2025. Research in the lab is aimed at understanding the causes and pathomechanisms of autoimmune diseases affecting the nervous system, particularly multiple sclerosis and myasthenia gravis.

The first position (expected start Summer 2024) is focussed on myasthenia gravis, and will include (i) involvement in a pre-defined international study of patient biosamples with a strong clinical component, and (ii) a somewhat higher risk basic science component looking at the normal. 

Application Deadline: April 30, 2024.


LihatTutupKomentar